Search - tctmd.com

Displaying 521 - 540 of 820

Sort: Relevancy | Date

News Daily News

DIY Adjunctive Radiation Shields Can Reduce Operator Exposure at Pelvis by 70%

L.A. McKeown

February 18, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Industry News

Robocath’s R-One™ robot acquired by the Medical Training & Testing Center in Rouen for future healthcare practitioner training

January 22, 2019

News Daily News

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

L.A. McKeown

January 21, 2019

News Daily News

Interventional Career? Female Fellows Repelled by ‘Old Boys Club,’ Radiation Risks, and Physical Demands

Yael L. Maxwell

January 17, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

News Daily News

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

Michael O'Riordan

January 15, 2019

News Daily News

FDA Approves Pea-Sized Occluder for Patent Ductus Arteriosus in Premature Babies

L.A. McKeown

January 14, 2019

News Featured Fellow

Marinos Charalambous, MD

Yael L. Maxwell

January 09, 2019

News Daily News

Operators’ Radiation Exposure in the Cath Lab Directly Tied to Patient BMI

Todd Neale

January 04, 2019

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

L.A. McKeown

December 17, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2018

Shelley Wood

November 30, 2018

News Daily News

Treating to New Blood Pressure Goals Could Prevent Millions of CVD Events

L.A. McKeown

November 21, 2018

News Daily News

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

Yael L. Maxwell

November 14, 2018

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

L.A. McKeown

November 09, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2018

Shelley Wood

October 31, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

Advertisement

DIY Adjunctive Radiation Shields Can Reduce Operator Exposure at Pelvis by 70%

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

TCTMD’s Top 10 Most Popular Stories for January 2019

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

Robocath’s R-One™ robot acquired by the Medical Training & Testing Center in Rouen for future healthcare practitioner training

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

Interventional Career? Female Fellows Repelled by ‘Old Boys Club,’ Radiation Risks, and Physical Demands

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

FDA Approves Pea-Sized Occluder for Patent Ductus Arteriosus in Premature Babies

Marinos Charalambous, MD

Operators’ Radiation Exposure in the Cath Lab Directly Tied to Patient BMI

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

TCTMD’s Top 10 Most Popular Stories for November 2018

Treating to New Blood Pressure Goals Could Prevent Millions of CVD Events

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

TCTMD’s Top 10 Most Popular Stories for October 2018

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content